大家健康(中旬版)
大傢健康(中旬版)
대가건강(중순판)
GOOD HEALTH FOR ALL
2014年
7期
10-10
,共1页
顽固性心力衰竭%左西孟旦%临床疗效%安全性
頑固性心力衰竭%左西孟旦%臨床療效%安全性
완고성심력쇠갈%좌서맹단%림상료효%안전성
obstinate heart failure%levosimendan%clinical effect%safety
目的:探讨左西孟旦治疗顽固性心力衰竭患者的疗效及安全性。方法:选取我院收治的47例顽固性心力衰竭患者作为研究对象,患者在常规治疗基础上给予左西孟旦治疗,观察临床治疗效果,记录不良反应情况。结果:治疗后患者的LVEF、SV、CI及NT-proBN水平较治疗前有显著改善,差异有统计学意义(P<0.05)。治疗期间2例患者出现头痛,1例患者出现低钾血症,不良反应发生率为6.4%。结论:左西孟旦治疗顽固性心力衰竭患者能够取得较好的临床疗效,安全性尚佳。
目的:探討左西孟旦治療頑固性心力衰竭患者的療效及安全性。方法:選取我院收治的47例頑固性心力衰竭患者作為研究對象,患者在常規治療基礎上給予左西孟旦治療,觀察臨床治療效果,記錄不良反應情況。結果:治療後患者的LVEF、SV、CI及NT-proBN水平較治療前有顯著改善,差異有統計學意義(P<0.05)。治療期間2例患者齣現頭痛,1例患者齣現低鉀血癥,不良反應髮生率為6.4%。結論:左西孟旦治療頑固性心力衰竭患者能夠取得較好的臨床療效,安全性尚佳。
목적:탐토좌서맹단치료완고성심력쇠갈환자적료효급안전성。방법:선취아원수치적47례완고성심력쇠갈환자작위연구대상,환자재상규치료기출상급여좌서맹단치료,관찰림상치료효과,기록불량반응정황。결과:치료후환자적LVEF、SV、CI급NT-proBN수평교치료전유현저개선,차이유통계학의의(P<0.05)。치료기간2례환자출현두통,1례환자출현저갑혈증,불량반응발생솔위6.4%。결론:좌서맹단치료완고성심력쇠갈환자능구취득교호적림상료효,안전성상가。
Objective:To study the clinical effect and safety of levosimendan in treatment of obstinate heart failure.Methods:47 cases of obstinate heart fail-ure in our hospital were selected as the research object,based on conventional treatment cases were treated by levosimendan,observed clinical effect and record adverse reactions.Results:After treatment LVEF,SV,CI and NT-proBN levels of cases were better than before,the difference was statistically significant (P<0.05).2 cases occurred of patients with headache,1 case had hypokalemia during treatment,the rate of adverse reaction was 6.4%.Conclusions:Taking levosimendan in treatment of obstinate heart failure can achieve better clinical effect,and the safety is good.